Rene Sindlev, Director, 10% Owner at Enochian Biosciences Inc (ENOB), bought 253,493 shares at $8.00 ($2.0M) on 2022-05-18, disclosed to the SEC on 2022-05-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.00 | 125,000 | $1.0M | 49.3% |
| 2 | $8.00 | 128,493 | $1.0M | 50.7% |
| Total | $8.00 avg | 253,493 | $2.0M | 100% |
| Filing → |
| ENOB | BUY | 2019-06-05 | $132K | — | Filing → |
| ENOB | BUY | 2019-06-05 | $268K | — | Filing → |
| ENOB | BUY | 2019-06-05 | $239K | — | Filing → |